Skip to main content
Top
Published in: Diabetologia 2/2018

Open Access 01-02-2018 | Review

Translating aetiological insight into sustainable management of type 2 diabetes

Authors: Roy Taylor, Alison C. Barnes

Published in: Diabetologia | Issue 2/2018

Login to get access

Abstract

Using a low-energy diet as a tool, it has been possible to elucidate the sequence of pathophysiological changes that lead to the onset of type 2 diabetes. Negative energy balance in type 2 diabetes causes a profound fall in liver fat content resulting in normalisation of hepatic insulin sensitivity within 7 days. As the period of negative energy balance extends and liver fat levels fall to low normal, the rate of export of triacylglycerol from the liver falls. Consequent to this, the raised pancreas fat content falls and in early type 2 diabetes, normal first-phase insulin secretion becomes re-established with normal plasma glucose control. This research, driven by the predictions of the 2008 twin cycle hypothesis, has led to a paradigm shift in understanding. Studying the reversed sequence of pathophysiological changes, the linked abnormalities in liver and pancreas have been revealed. Early type 2 diabetes is a potentially reversible condition. Surprisingly, it was observed that the diet devised as an experimental tool was actually liked by research participants. It was associated neither with hunger nor tiredness in most people, but with rapidly increased wellbeing. A defined period of weight loss followed by carefully planned weight maintenance—the ‘One, Two’ approach—has since been applied in clinical practice. Motivated individuals can reverse their type 2 diabetes and remain normoglycaemic over years. A large study is underway to evaluate the applicability of this general approach to routine primary care practice as a long-term management strategy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Taylor R (2008) Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 51:1781–1789CrossRefPubMed Taylor R (2008) Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 51:1781–1789CrossRefPubMed
2.
go back to reference Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506–2514CrossRefPubMedPubMedCentral Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506–2514CrossRefPubMedPubMedCentral
3.
go back to reference Steven S, Hollingsworth KG, Small P et al (2016) Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care 39:158–165CrossRefPubMed Steven S, Hollingsworth KG, Small P et al (2016) Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care 39:158–165CrossRefPubMed
4.
go back to reference Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed
5.
go back to reference Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755–765CrossRefPubMed Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755–765CrossRefPubMed
6.
go back to reference Lalloyer F, Vandewalle B, Percevault F et al (2006) Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 55:1605–1613CrossRefPubMed Lalloyer F, Vandewalle B, Percevault F et al (2006) Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 55:1605–1613CrossRefPubMed
7.
go back to reference White MG, Shaw JAM, Taylor R (2016) Type 2 diabetes: the pathologic basis of reversible beta-cell dysfunction. Diabetes Care 39:2080–2088CrossRefPubMed White MG, Shaw JAM, Taylor R (2016) Type 2 diabetes: the pathologic basis of reversible beta-cell dysfunction. Diabetes Care 39:2080–2088CrossRefPubMed
9.
go back to reference Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39:808–815CrossRefPubMed Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39:808–815CrossRefPubMed
10.
go back to reference Taylor R, Holman R (2015) Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci 128:405–410CrossRefPubMed Taylor R, Holman R (2015) Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci 128:405–410CrossRefPubMed
11.
go back to reference Robbins AL, Savage DB (2015) The genetics of lipid storage and human lipodystrophies. Trends Mol Med 21:433–438CrossRefPubMed Robbins AL, Savage DB (2015) The genetics of lipid storage and human lipodystrophies. Trends Mol Med 21:433–438CrossRefPubMed
12.
go back to reference Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective. Biochim Biophys Acta 1801:338–349CrossRefPubMed Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective. Biochim Biophys Acta 1801:338–349CrossRefPubMed
13.
go back to reference Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486CrossRefPubMed Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486CrossRefPubMed
14.
go back to reference UKPDS (1991) UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34:877–890CrossRef UKPDS (1991) UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34:877–890CrossRef
15.
go back to reference Rosenbaum S, Skinner RK, Knight IB, Garrow JS (1985) A survey of heights and weights of adults in Great Britain, 1980. Ann Hum Biol 12:115–127CrossRefPubMed Rosenbaum S, Skinner RK, Knight IB, Garrow JS (1985) A survey of heights and weights of adults in Great Britain, 1980. Ann Hum Biol 12:115–127CrossRefPubMed
16.
go back to reference Pinnick K, Neville M, Clark A, Fielding B (2010) Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids. J Cell Biochem 109:683–692PubMed Pinnick K, Neville M, Clark A, Fielding B (2010) Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids. J Cell Biochem 109:683–692PubMed
17.
go back to reference Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA (2008) Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 16:522–530CrossRefPubMed Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA (2008) Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 16:522–530CrossRefPubMed
18.
go back to reference Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223–1234CrossRefPubMedPubMedCentral Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223–1234CrossRefPubMedPubMedCentral
19.
go back to reference White MG, Marshall HL, Rigby R et al (2013) Expression of mesenchymal and alpha-cell phenotypic markers in islet beta-cells in recently diagnosed diabetes. Diabetes Care 36:3818–3820CrossRefPubMedPubMedCentral White MG, Marshall HL, Rigby R et al (2013) Expression of mesenchymal and alpha-cell phenotypic markers in islet beta-cells in recently diagnosed diabetes. Diabetes Care 36:3818–3820CrossRefPubMedPubMedCentral
20.
go back to reference Cali AM, Man CD, Cobelli C et al (2009) Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 32:456–461CrossRefPubMedPubMedCentral Cali AM, Man CD, Cobelli C et al (2009) Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 32:456–461CrossRefPubMedPubMedCentral
21.
go back to reference Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160–165CrossRefPubMed Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160–165CrossRefPubMed
22.
go back to reference Macauley M, Percival K, Thelwall PE, Hollingsworth KG, Taylor R (2015) Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One 10:e0126825CrossRefPubMedPubMedCentral Macauley M, Percival K, Thelwall PE, Hollingsworth KG, Taylor R (2015) Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One 10:e0126825CrossRefPubMedPubMedCentral
23.
go back to reference Al-Mrabeh A, Hollingsworth KG, Steven S, Taylor R (2016) Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity. Diabetologia 59:1753–1759CrossRefPubMedPubMedCentral Al-Mrabeh A, Hollingsworth KG, Steven S, Taylor R (2016) Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity. Diabetologia 59:1753–1759CrossRefPubMedPubMedCentral
24.
go back to reference Yamazaki H, Tsuboya T, Katanuma A et al (2016) Lack of independent associationbetween fatty pancreas and incidence of type 2 diabetes: 5-year Japanese cohort study. Diabetes Care 39:1677–1683CrossRefPubMed Yamazaki H, Tsuboya T, Katanuma A et al (2016) Lack of independent associationbetween fatty pancreas and incidence of type 2 diabetes: 5-year Japanese cohort study. Diabetes Care 39:1677–1683CrossRefPubMed
25.
go back to reference van der Zijl NJ, Goossens GH, Moors CC et al (2011) Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96:459–467 van der Zijl NJ, Goossens GH, Moors CC et al (2011) Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96:459–467
26.
go back to reference Kuhn JP, Berthold F, Mayerle J et al (2015) Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 276:129–136 Kuhn JP, Berthold F, Mayerle J et al (2015) Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 276:129–136
27.
28.
go back to reference Skyler JS, Bakris GL, Bonifacio E et al (2017) Differentiation of diabetes by pathophysiology, natural history, and prognosis. diabetes 66:241–255 Skyler JS, Bakris GL, Bonifacio E et al (2017) Differentiation of diabetes by pathophysiology, natural history, and prognosis. diabetes 66:241–255
29.
go back to reference Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084–1094CrossRefPubMed Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084–1094CrossRefPubMed
30.
go back to reference van Rijn-Bikker PC, Mairuhu G, van Montfrans GA et al (2009) Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Am J Hypertens 22:1295–1302CrossRefPubMed van Rijn-Bikker PC, Mairuhu G, van Montfrans GA et al (2009) Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Am J Hypertens 22:1295–1302CrossRefPubMed
31.
go back to reference Franco M, Bilal U, Ordunez P et al (2013) Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ f1515:346 Franco M, Bilal U, Ordunez P et al (2013) Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ f1515:346
32.
go back to reference Himsworth HP (1949) Diet in the aetiology of human diabetes. Proc R Soc Med 42:323–326 Himsworth HP (1949) Diet in the aetiology of human diabetes. Proc R Soc Med 42:323–326
33.
go back to reference Hrdlička A (1908) Physiological and medical observations amongs the Indians of southwestern United States and north Mexico. Washington Government Printing Office, Washington DC Hrdlička A (1908) Physiological and medical observations amongs the Indians of southwestern United States and north Mexico. Washington Government Printing Office, Washington DC
34.
go back to reference Joslin EP (1940) The universality of diabetes: a survey of diabetes mortality in Arizona. JAMA 115:2033–2038CrossRef Joslin EP (1940) The universality of diabetes: a survey of diabetes mortality in Arizona. JAMA 115:2033–2038CrossRef
35.
go back to reference Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19 fold greater incidence than in Rochester Minnesota. Am J Epidemiol 108:497–505CrossRefPubMed Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19 fold greater incidence than in Rochester Minnesota. Am J Epidemiol 108:497–505CrossRefPubMed
36.
37.
38.
go back to reference Leslie WS, Taylor R, Harris L, Lean ME (2017) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes 41:96–101 Leslie WS, Taylor R, Harris L, Lean ME (2017) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes 41:96–101
40.
go back to reference Steven S, Lim E, Taylor R (2013) Population response to information on reversibility of type 2 diabetes. Diabet Med 30:e135–e138CrossRefPubMed Steven S, Lim E, Taylor R (2013) Population response to information on reversibility of type 2 diabetes. Diabet Med 30:e135–e138CrossRefPubMed
41.
go back to reference Johansson K, Neovius M, Hemmingsson E (2014) Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 99:14–23CrossRefPubMed Johansson K, Neovius M, Hemmingsson E (2014) Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 99:14–23CrossRefPubMed
42.
go back to reference Gripeteg L, Torgerson J, Karlsson J, Lindroos AK (2010) Prolonged refeeding improves weight maintenance after weight loss with very-low-energy diets. Br J Nutr 103:141–148CrossRefPubMed Gripeteg L, Torgerson J, Karlsson J, Lindroos AK (2010) Prolonged refeeding improves weight maintenance after weight loss with very-low-energy diets. Br J Nutr 103:141–148CrossRefPubMed
43.
go back to reference Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO (1990) A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51:241–247PubMed Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO (1990) A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51:241–247PubMed
44.
go back to reference Shieh C, Knisely MR, Clark D, Carpenter JS (2016) Self-weighing in weight management interventions: A systematic review of literature. Obes Res Clin Pract 10:493–519CrossRefPubMed Shieh C, Knisely MR, Clark D, Carpenter JS (2016) Self-weighing in weight management interventions: A systematic review of literature. Obes Res Clin Pract 10:493–519CrossRefPubMed
45.
go back to reference Middleton KMR, Patidar SM, Perri MG (2012) The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 13:509–517CrossRefPubMed Middleton KMR, Patidar SM, Perri MG (2012) The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 13:509–517CrossRefPubMed
46.
go back to reference MacLean PS, Wing RR, Davidson T et al (2015) NIH Working Group Report: innovative research to improve maintenance of weight loss. Obesity 23:7–15CrossRefPubMed MacLean PS, Wing RR, Davidson T et al (2015) NIH Working Group Report: innovative research to improve maintenance of weight loss. Obesity 23:7–15CrossRefPubMed
47.
go back to reference Lean M, Brosnahan N, McLoone P et al (2013) Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract 63:e115–e124 Lean M, Brosnahan N, McLoone P et al (2013) Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract 63:e115–e124
48.
go back to reference Keys A (1953) Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp N Y 20:118–139PubMed Keys A (1953) Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp N Y 20:118–139PubMed
49.
go back to reference Feinman RD, Pogozelski WK, Astrup A et al (2015) Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31:1–13CrossRefPubMed Feinman RD, Pogozelski WK, Astrup A et al (2015) Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31:1–13CrossRefPubMed
50.
go back to reference Dyson PA, Kelly T, Deakin T et al (2011) Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 28:1282–1288CrossRefPubMed Dyson PA, Kelly T, Deakin T et al (2011) Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 28:1282–1288CrossRefPubMed
51.
go back to reference Spiro A, Stanner S (2016) The National Obesity Forum report is an opinion piece not a scientific review. Nutr Bull 41:257–269CrossRef Spiro A, Stanner S (2016) The National Obesity Forum report is an opinion piece not a scientific review. Nutr Bull 41:257–269CrossRef
52.
go back to reference van Wyk HJ, Davis RE, Davies JS (2016) A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med 33:148–157 van Wyk HJ, Davis RE, Davies JS (2016) A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med 33:148–157
53.
go back to reference de Souza RJ, Bray GA, Carey VJ et al (2012) Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr 95:614–625CrossRefPubMedPubMedCentral de Souza RJ, Bray GA, Carey VJ et al (2012) Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr 95:614–625CrossRefPubMedPubMedCentral
54.
go back to reference McArdle PD, Greenfield SM, Avery A, Adams GG, Gill PS (2017) Dietitians’ practice in giving carbohydrate advice in the management of type 2 diabetes: a mixed methods study. J Hum Nutr Diet 30:385–393CrossRefPubMed McArdle PD, Greenfield SM, Avery A, Adams GG, Gill PS (2017) Dietitians’ practice in giving carbohydrate advice in the management of type 2 diabetes: a mixed methods study. J Hum Nutr Diet 30:385–393CrossRefPubMed
56.
go back to reference Estruch R, Martinez-Gonzalez MA, Corella D et al (2016) Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol 4:666–676CrossRefPubMed Estruch R, Martinez-Gonzalez MA, Corella D et al (2016) Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol 4:666–676CrossRefPubMed
57.
go back to reference Garcia-Fernandez E, Rico-Cabanas L, Rosgaard N, Estruch R, Bach-Faig A (2014) Mediterranean diet and cardiodiabesity: a review. Nutrients 6:3474–3500CrossRefPubMedPubMedCentral Garcia-Fernandez E, Rico-Cabanas L, Rosgaard N, Estruch R, Bach-Faig A (2014) Mediterranean diet and cardiodiabesity: a review. Nutrients 6:3474–3500CrossRefPubMedPubMedCentral
58.
go back to reference Martinez-Gonzalez MA, Martin-Calvo N (2016) Mediterranean diet and life expectancy; beyond olive oil, fruits, and vegetables. Curr Opin Clin Nutr Metab Care 19:401–407CrossRefPubMed Martinez-Gonzalez MA, Martin-Calvo N (2016) Mediterranean diet and life expectancy; beyond olive oil, fruits, and vegetables. Curr Opin Clin Nutr Metab Care 19:401–407CrossRefPubMed
59.
go back to reference Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRefPubMed Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRefPubMed
60.
go back to reference Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D (2014) The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care 37:1824–1830CrossRefPubMed Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D (2014) The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care 37:1824–1830CrossRefPubMed
61.
go back to reference Davis CS, Clarke RE, Coulter SN et al (2016) Intermittent energy restriction and weight loss: a systematic review. Eur J Clin Nutr 70:292–299CrossRefPubMed Davis CS, Clarke RE, Coulter SN et al (2016) Intermittent energy restriction and weight loss: a systematic review. Eur J Clin Nutr 70:292–299CrossRefPubMed
62.
go back to reference Harvie M, Wright C, Pegington M et al (2013) The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr 110:1534–1547CrossRefPubMed Harvie M, Wright C, Pegington M et al (2013) The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr 110:1534–1547CrossRefPubMed
63.
go back to reference Carter S, Clifton PM, Keogh JB (2016) The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 122:106–112CrossRefPubMed Carter S, Clifton PM, Keogh JB (2016) The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 122:106–112CrossRefPubMed
64.
go back to reference Harvie MN, Howell T (2016) Could intermittent energy restriction and intermittent fasting reduce rates of cancer in obese, overweight, and normal-weight subjects? A summary of evidence. Advances in Nutrition 7:690–705 Harvie MN, Howell T (2016) Could intermittent energy restriction and intermittent fasting reduce rates of cancer in obese, overweight, and normal-weight subjects? A summary of evidence. Advances in Nutrition 7:690–705
65.
go back to reference Brown AW, Bohan Brown MM, Allison DB (2013) Belief beyond the evidence: using the proposed effect of breakfast on obesity to show 2 practices that distort scientific evidence. Am J Clin Nutr 98:1298–1308CrossRefPubMedPubMedCentral Brown AW, Bohan Brown MM, Allison DB (2013) Belief beyond the evidence: using the proposed effect of breakfast on obesity to show 2 practices that distort scientific evidence. Am J Clin Nutr 98:1298–1308CrossRefPubMedPubMedCentral
66.
go back to reference Clayton DJ, Stensel DJ, James LJ (2016) Effect of breakfast omission on subjective appetite, metabolism, acylated ghrelin and GLP-17-36 during rest and exercise. Nutrition 32:179–185CrossRefPubMed Clayton DJ, Stensel DJ, James LJ (2016) Effect of breakfast omission on subjective appetite, metabolism, acylated ghrelin and GLP-17-36 during rest and exercise. Nutrition 32:179–185CrossRefPubMed
67.
go back to reference Kealey T (2016) Breakfast is a dangerous meal. 4th Estate, London Kealey T (2016) Breakfast is a dangerous meal. 4th Estate, London
68.
go back to reference Wing RR, Phelan S (2005) Long-term weight loss maintenance. Am J Clin Nutr 82:222S–225SPubMed Wing RR, Phelan S (2005) Long-term weight loss maintenance. Am J Clin Nutr 82:222S–225SPubMed
69.
go back to reference Finlayson G, Bryant E, Blundell JE, King NA (2009) Acute compensatory eating following exercise is associated with implicit hedonic wanting for food. Physiol Behav 97:62–67CrossRefPubMed Finlayson G, Bryant E, Blundell JE, King NA (2009) Acute compensatory eating following exercise is associated with implicit hedonic wanting for food. Physiol Behav 97:62–67CrossRefPubMed
70.
go back to reference Hopkins M, Blundell JE, King NA (2014) Individual variability in compensatory eating following acute exercise in overweight and obese women. Br J Sports Med 48:1472–1476CrossRefPubMed Hopkins M, Blundell JE, King NA (2014) Individual variability in compensatory eating following acute exercise in overweight and obese women. Br J Sports Med 48:1472–1476CrossRefPubMed
71.
go back to reference King NA, Horner K, Hills AP et al (2012) Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss. Br J Sports Med 46:315–322CrossRefPubMed King NA, Horner K, Hills AP et al (2012) Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss. Br J Sports Med 46:315–322CrossRefPubMed
72.
go back to reference LookAhead (2014) Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity 22:5–13CrossRef LookAhead (2014) Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity 22:5–13CrossRef
73.
go back to reference Sheth H, Sheth J, Sheth F, Burn J (2016) The poor patient with diabetes ‘should live like a saint’. Diabet Med 33:134–135 Sheth H, Sheth J, Sheth F, Burn J (2016) The poor patient with diabetes ‘should live like a saint’. Diabet Med 33:134–135
74.
go back to reference Bouchardat A (1875) De la glycosurie ou diabète sucré. Librarie G. Baillière, Paris [document in French] Bouchardat A (1875) De la glycosurie ou diabète sucré. Librarie G. Baillière, Paris [document in French]
75.
76.
go back to reference Friedman MN, Sancetta AJ, Magovern GJ (1955) The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 100:201–204PubMed Friedman MN, Sancetta AJ, Magovern GJ (1955) The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 100:201–204PubMed
77.
go back to reference Lara-Castro C, Newcomer BR, Rowell J et al (2008) Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metab Clin Exp 57:1–8CrossRefPubMedPubMedCentral Lara-Castro C, Newcomer BR, Rowell J et al (2008) Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metab Clin Exp 57:1–8CrossRefPubMedPubMedCentral
78.
go back to reference Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH (1991) Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 151:1334–1340CrossRefPubMed Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH (1991) Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 151:1334–1340CrossRefPubMed
79.
go back to reference Paisey RB, Frost J, Harvey P et al (2002) Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet 15:121–127CrossRefPubMed Paisey RB, Frost J, Harvey P et al (2002) Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet 15:121–127CrossRefPubMed
80.
go back to reference Henry RR, Wallace P, Olefsky JM (1986) Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus. Diabetes 35:990–998CrossRefPubMed Henry RR, Wallace P, Olefsky JM (1986) Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus. Diabetes 35:990–998CrossRefPubMed
81.
go back to reference UKPDS (1999) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 UKPDS (1999) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
82.
go back to reference Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed
83.
go back to reference UKPDS (1995) UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258 UKPDS (1995) UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258
84.
go back to reference UKPDS (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854–865CrossRef UKPDS (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854–865CrossRef
85.
go back to reference Taylor R (2016) Calorie restriction and reversal of type 2 diabetes. Expert Rev Endocrinol Metab 11:521–528CrossRef Taylor R (2016) Calorie restriction and reversal of type 2 diabetes. Expert Rev Endocrinol Metab 11:521–528CrossRef
Metadata
Title
Translating aetiological insight into sustainable management of type 2 diabetes
Authors
Roy Taylor
Alison C. Barnes
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4504-z

Other articles of this Issue 2/2018

Diabetologia 2/2018 Go to the issue